- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: ABT-874 | J-695 | J695 | Ozespa
Compound class: Antibody
Comment: Briakinumab is a recombinant, fully human, IgG1 investigational monoclonal antibody targeting the shared p40 subunit of IL-12 and IL-23. Peptide sequences matching those of briakinumab are claimed in patent US6914128 'Human antibodies that bind human IL-12 and methods for producing' .
View more information in the IUPHAR Pharmacology Education Project: pericyazine